Park National Boosted Its Novartis Ag Sponsored Adr (NVS) Holding; Northern Trust Decreased Sonoco Prods Co (SON) Position By $1.04 Million

Park National Corp increased Novartis Ag Sponsored Adr (NVS) stake by 2.38% reported in 2017Q3 SEC filing. Park National Corp acquired 7,091 shares as Novartis Ag Sponsored Adr (NVS)’s stock rose 4.17%. The Park National Corp holds 304,981 shares with $26.18M value, up from 297,890 last quarter. Novartis Ag Sponsored Adr now has $194.14B valuation. The stock increased 0.24% or $0.2 during the last trading session, reaching $82.96. About 652,875 shares traded. Novartis AG (NYSE:NVS) has risen 7.67% since March 12, 2017 and is uptrending. It has underperformed by 9.03% the S&P500.

Northern Trust Corp decreased Sonoco Prods Co (SON) stake by 2.38% reported in 2017Q3 SEC filing. Northern Trust Corp sold 20,828 shares as Sonoco Prods Co (SON)’s stock declined 4.77%. The Northern Trust Corp holds 855,058 shares with $43.14M value, down from 875,886 last quarter. Sonoco Prods Co now has $4.86B valuation. The stock decreased 0.22% or $0.11 during the last trading session, reaching $48.89. About 254,870 shares traded. Sonoco Products Company (NYSE:SON) has risen 9.55% since March 12, 2017 and is uptrending. It has underperformed by 7.15% the S&P500.

Park National Corp decreased Park National Corporation (NYSEMKT:PRK) stake by 115,606 shares to 1.83 million valued at $197.25M in 2017Q3. It also reduced Flexshares Stoxx Global Broad (NFRA) stake by 10,039 shares and now owns 18,099 shares. Texas Instruments Inc (NASDAQ:TXN) was reduced too.

Among 16 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 4 Sell and 7 Hold. Therefore 31% are positive. Novartis Ag has $110 highest and $7700 lowest target. $96.80’s average target is 16.68% above currents $82.96 stock price. Novartis Ag had 36 analyst reports since July 28, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Goldman Sachs on Thursday, March 23. On Friday, March 24 the stock rating was maintained by JP Morgan with “Neutral”. Morgan Stanley upgraded the shares of NVS in report on Wednesday, July 26 to “Overweight” rating. The stock has “Hold” rating by Cowen & Co on Tuesday, July 18. The stock of Novartis AG (NYSE:NVS) has “Market Perform” rating given on Thursday, January 25 by Leerink Swann. Barclays Capital downgraded Novartis AG (NYSE:NVS) on Wednesday, October 25 to “Sell” rating. The stock of Novartis AG (NYSE:NVS) earned “Market Perform” rating by Cowen & Co on Wednesday, April 5. The firm has “Neutral” rating given on Wednesday, April 19 by JP Morgan. The firm has “Buy” rating given on Thursday, November 10 by Argus Research. Bank of America downgraded Novartis AG (NYSE:NVS) on Wednesday, December 6 to “Sell” rating.

Analysts await Sonoco Products Company (NYSE:SON) to report earnings on April, 19. They expect $0.72 earnings per share, up 22.03% or $0.13 from last year’s $0.59 per share. SON’s profit will be $71.63M for 16.98 P/E if the $0.72 EPS becomes a reality. After $0.72 actual earnings per share reported by Sonoco Products Company for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Among 13 analysts covering Sonoco Products Company (NYSE:SON), 3 have Buy rating, 1 Sell and 9 Hold. Therefore 23% are positive. Sonoco Products Company had 37 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Sonoco Products Company (NYSE:SON) earned “Sell” rating by Zacks on Tuesday, September 1. As per Tuesday, August 25, the company rating was downgraded by Zacks. KeyBanc Capital Markets maintained Sonoco Products Company (NYSE:SON) on Sunday, December 3 with “Hold” rating. The rating was upgraded by Robert W. Baird on Wednesday, July 19 to “Outperform”. As per Friday, December 9, the company rating was downgraded by Argus Research. The rating was upgraded by Zacks on Friday, August 7 to “Sell”. The rating was maintained by BMO Capital Markets with “Hold” on Wednesday, July 19. Jefferies maintained the stock with “Hold” rating in Thursday, July 14 report. The firm has “Hold” rating by KeyBanc Capital Markets given on Wednesday, September 20. The stock of Sonoco Products Company (NYSE:SON) has “Sell” rating given on Friday, July 21 by Vertical Research.

Investors sentiment decreased to 1.14 in 2017 Q3. Its down 0.05, from 1.19 in 2017Q2. It fall, as 26 investors sold SON shares while 98 reduced holdings. 36 funds opened positions while 112 raised stakes. 69.34 million shares or 1.59% less from 70.45 million shares in 2017Q2 were reported. Paloma Ptnrs invested in 0.03% or 49,517 shares. First Allied Advisory Ser Inc has invested 0.22% in Sonoco Products Company (NYSE:SON). Wedge Cap Mngmt L Lp Nc holds 0% of its portfolio in Sonoco Products Company (NYSE:SON) for 10,163 shares. Northwestern Mutual Wealth Management Co has 0.01% invested in Sonoco Products Company (NYSE:SON) for 16,085 shares. 11,165 were accumulated by Profund Ltd Llc. Moreover, Bnp Paribas Arbitrage Sa has 0.01% invested in Sonoco Products Company (NYSE:SON) for 68,877 shares. Brandywine Glob Invest Mngmt Limited has invested 0.03% in Sonoco Products Company (NYSE:SON). Bokf Na reported 4,349 shares. Raymond James owns 48,693 shares or 0% of their US portfolio. Fdx Advsrs, a California-based fund reported 21,695 shares. The California-based United Cap Advisers Ltd Com has invested 0.02% in Sonoco Products Company (NYSE:SON). Regentatlantic Limited reported 4,810 shares. Metropolitan Life Company reported 93,469 shares. Wharton Business Group Ltd Llc holds 0.83% or 155,925 shares. Gemmer Asset Mgmt invested in 187 shares.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter:



 

Recent Posts